Edition:
United Kingdom

Opiant Pharmaceuticals Inc (OPNT.OQ)

OPNT.OQ on NASDAQ Stock Exchange Capital Market

15.25USD
20 Jul 2018
Change (% chg)

$0.69 (+4.74%)
Prev Close
$14.56
Open
$14.83
Day's High
$15.25
Day's Low
$14.68
Volume
2,993
Avg. Vol
8,107
52-wk High
$51.90
52-wk Low
$12.75

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 1.70 -3.676
FY 2017 Dec '17 11.74 0.611
Oct '17 0.02 -2.772
Jan '17 13.53 4.908
Oct 1.12 -0.301
FY 2016 Jul '16 0.31 -0.546
Apr '16 2.61 0.152
Jan '16 6.86 1.524
Oct 0.12 -6.005
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 14.34 30.93 32.76
P/E High - Last 5 Yrs. -- 40.66 45.44
P/E Low - Last 5 Yrs. -- 23.70 24.26
Beta -0.31 0.90 0.89
Price to Sales (TTM) 4.86 3.94 5.73
Price to Book (MRQ) 16.95 4.88 5.47
Price to Tangible Book (MRQ) 17.07 5.70 7.05
Price to Cash Flow (TTM) -- 22.85 23.29
% Owned Institutions 1.32 1.23 2.21

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.51
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.35 5.22
Payout Ratio(TTM) 0.00 45.85 43.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -99.30 2.28 8.01
Sales (TTM) vs TTM 1 Yr. Ago 43.34 4.77 5.64
Sales - 5 Yr. Growth Rate -- 9.94 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -1,121.18 17.61 20.60
EPS (TTM) vs TTM 1 Yr. Ago 148.03 -- --
EPS - 5 Yr. Growth Rate -- 9.75 10.66
Capital Spending - 5 Yr. Growth Rate -- 15.37 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.22
Current Ratio (MRQ) 3.13 2.94 3.03
LT Debt to Equity (MRQ) 0.00 10.03 12.51
Total Debt to Equity (MRQ) 0.00 14.07 16.84
Interest Coverage (TTM) -57.11 35.78 32.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.72 54.37
Gross Margin - 5 Yr. Avg. -- 52.10 52.17
EBITD Margin (TTM) 39.02 -- --
EBITD - 5 Yr. Avg -411.24 18.50 10.81
Operating Margin (TTM) 38.98 14.31 4.58
Operating Margin - 5 Yr. Avg. -411.30 14.45 6.23
Pre-Tax Margin (TTM) 38.90 14.80 5.43
Pre-Tax Margin - 5 Yr. Avg. -418.72 14.86 6.67
Net Profit Margin (TTM) 38.90 11.05 1.73
Net Profit Margin - 5 Yr. Avg. -418.72 11.16 2.94
Effective Tax Rate (TTM) 0.00 23.22 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.49 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 953,055,695 860,394,083
Net Income/Employee (TTM) -- 112,126,539 101,209,433
Receivable Turnover (TTM) -- 5.72 5.87
Inventory Turnover (TTM) -- 2.63 3.41
Asset Turnover (TTM) 2.44 0.96 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 95.09 11.58 11.14
Return on Assets - 5 Yr. Avg. -1,951.46 12.95 12.40
Return on Investment (TTM) 231.11 15.07 14.61
Return on Investment - 5 Yr. Avg. -- 16.90 16.14
Return on Equity (TTM) 2,031.09 16.60 16.34
Return on Equity - 5 Yr. Avg. -- 17.97 17.40
  1 Year 3 Year 5 Year
Sales % 538.55 -- --
EPS (TTM) % -5.37 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Opiant Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 4.65%
# of Holders: 16
Total Shares Held: 125,526
3 Mo. Net Change: 13,581
# New Positions: 3
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 0
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.